Share  The Federal Competition and Consumer Protection Commission (FCCPC) has beamed a searchlight on escalating costs and price disparities of blood pressure (BP) and diabetic drugs across various markets in the country. Speaking at a stakeholder engagement session held in Abuja, on Wednesday, the Executive Vice Chairman of the FCCPC, Tunji Bello, emphasized that the...

The post FCCPC Probes Discrepancies Of BP, Diabetic Drugs appeared first on New Telegraph.